Hospitals SpinalCyte Applies with FDA to Expand Human Clinical Trial of CybroCell™ Dermal Fibroblasts as Investigational New Drug (IND) byJosh SandbergApril 12, 2018
Biologics Phase 1/2 Clinical Trial Results Positive for SpinalCyte’s CybroCell™ Dermal Fibroblasts byJosh SandbergFebruary 14, 2018
